이상반응 보고
| VAERS ID | 1755150 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | FE1510 |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-29 |
| 발병일 | 2021-08-06 |
| 상태 | 입원 |
증상
- SARS-CoV-2 테스트(SARS-CoV-2 test)
- 복통(Abdominal pain)
- 자연 낙태(Abortion spontaneous)
- 초음파 태아(Ultrasound foetal)
- 임신 중 자궁 수축(Uterine contractions during pregnancy)
- 질 분비물(Vaginal discharge)
이환 중 질병
지병
Medical History/Concurrent Conditions: Folic acid supplementation; Pregnancy
기타 의료
Pfizer, Inc. EUA 027034
이전 예방접종
알레르기
임상 검사
Test Date: 20210722; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test; Test Name: scans; Result Unstructured Data: Test Result:normal; Comments: had three scans, including the 12 weeks and were all normal
증상 상세
Miscarriage; abdominal cramps; Uterine contractions during pregnancy; Vaginal discharge/light pink discharge; This is a spontaneous report received from a contactable consumer (patient) from the regulatory authority.
The regulatory authority report number is GB-MHRA-WEBCOVID-202109231333426060-KD3OH.
Safety Report Unique Identifier GB-MHRA-ADR 25984094.
A 37-year-old female patient received BNT162B2 (COVID-19 MRNA VACCINE BIONTECH), dose 1 via an unspecified route of administration on 29Jul2021 (Batch/Lot Number: FE1510) as DOSE 1, SINGLE for COVID-19 immunisation.
Medical history included Folic acid supplementation.
The patient was a healthy individual.
Patient has not had symptoms associated with COVID-19.
This was her third low risk pregnancy.
Concomitant medication included folic acid taken for vitamin supplementation.
The patient experienced abdominal cramps on 10Aug2021, miscarriage on 10Aug2021 23:30, Vaginal discharge/light pink discharge on 06Aug2021, uterine contractions during pregnancy on 10Aug2021.
The patient underwent lab tests and procedures which included sars-cov-2 test: negative covid-19 test on 22Jul2021.
The patient had three scans, including the 12 weeks and were all normal.
The patient was hospitalized.
The outcome of abdominal cramps and miscarriage was not recovered, outcome of other events was unknown.
The clinical course was reported as: The patient received the first dose of vaccine on Thursday 29Jul2021 (14 weeks pregnant).
The patient did not have any side effects but on Friday 06Aug2021 (8 days after the vaccination) she started to experience light pink discharge.
On Tuesday 10Aug2021, she started to have abdominal cramps and then contractions and miscarriage at 11:30 pm.
Patient has not tested positive for COVID-19 since having the vaccine.
Patient is not enrolled in clinical trial.
No follow-up attempts are needed.
No further information is expected.
; Sender's Comments: Linked Report(s) : GB-PFIZER INC-202101275587 baby